These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22389914)

  • 21. Oral mucosal involvement in visceral leishmaniasis.
    Garg S; Tripathi R; Tripathi K
    Asian Pac J Trop Med; 2013 Mar; 6(3):249-50. PubMed ID: 23375044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amphotericin B therapy in children with visceral leishmaniasis: daily vs. alternate day, a randomized trial.
    Singh UK; Prasad R; Jaiswal BP; Singh PK; Thakur CP
    J Trop Pediatr; 2010 Oct; 56(5):321-4. PubMed ID: 20065047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unusual case of resistance to amphotericin B in visceral leishmaniasis in a region in India where leishmaniasis is not endemic.
    Srivastava P; Prajapati VK; Rai M; Sundar S
    J Clin Microbiol; 2011 Aug; 49(8):3088-91. PubMed ID: 21613432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amphotericin B inhibits entry of Leishmania donovani into primary macrophages.
    Paila YD; Saha B; Chattopadhyay A
    Biochem Biophys Res Commun; 2010 Aug; 399(3):429-33. PubMed ID: 20678487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimony-induced cerebellar ataxia.
    Khalil EA; Ahmed AE; Musa AM; Hussein MH
    Saudi Med J; 2006 Jan; 27(1):90-2. PubMed ID: 16432602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness analysis of diagnostic-therapeutic strategies for visceral leishmaniasis in Brazil.
    Assis TSM; Rabello A; Cota G; Werneck GL; Azeredo-da-Silva ALF
    Rev Soc Bras Med Trop; 2019 Apr; 52():e20180272. PubMed ID: 30994802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug combinations for visceral leishmaniasis.
    Olliaro PL
    Curr Opin Infect Dis; 2010 Dec; 23(6):595-602. PubMed ID: 20871400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonmigrant children with visceral leishmaniasis from the nonendemic area of Uttarakhand.
    Mathur SB; Arya AK
    J Trop Pediatr; 2014 Aug; 60(4):322-5. PubMed ID: 24531375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laryngeal leishmaniasis: case report of a rare infection.
    Teemul TA; Giles-Lima M; Williams J; Lester SE
    Head Neck; 2013 Sep; 35(9):E277-9. PubMed ID: 22972594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study.
    Sundar S; Jha TK; Thakur CP; Mishra M; Singh VP; Buffels R
    Clin Infect Dis; 2003 Sep; 37(6):800-4. PubMed ID: 12955641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 7-month-old girl with fever and bleeding.
    Chaliasos N; Bourantas C; Kritikou E; Lapatsanis P
    Lancet; 1996 Apr; 347(9008):1086. PubMed ID: 8602061
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral miltefosine for Indian visceral leishmaniasis.
    Sundar S; Jha TK; Thakur CP; Engel J; Sindermann H; Fischer C; Junge K; Bryceson A; Berman J
    N Engl J Med; 2002 Nov; 347(22):1739-46. PubMed ID: 12456849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis.
    Shahnaz G; Edagwa BJ; McMillan J; Akhtar S; Raza A; Qureshi NA; Yasinzai M; Gendelman HE
    Nanomedicine (Lond); 2017 Jan; 12(2):99-115. PubMed ID: 27879160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acute pancreatitis during treatment with meglumine antimoniate (Glucantime)].
    Barthet M; Brunet P; Bernard JC; Dussol B; Rodor F; Jouglard J; Berland Y; Sahel J
    Gastroenterol Clin Biol; 1994; 18(1):90-2. PubMed ID: 8187998
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of visceral leishmaniasis.
    Sundar S; Rai M
    Expert Opin Pharmacother; 2005 Dec; 6(16):2821-9. PubMed ID: 16318433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single high dose treatment of kala-azar with Ambisome (amphotericin B lipid complex): a pilot study.
    Thakur CP
    Int J Antimicrob Agents; 2001 Jan; 17(1):67-70. PubMed ID: 11137652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An oral formulation of amphotericin B attached to functionalized carbon nanotubes is an effective treatment for experimental visceral leishmaniasis.
    Prajapati VK; Awasthi K; Yadav TP; Rai M; Srivastava ON; Sundar S
    J Infect Dis; 2012 Jan; 205(2):333-6. PubMed ID: 22158723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of visceral leishmaniasis unresponsive to pentamidine with amphotericin B.
    Mishra M
    J Assoc Physicians India; 1995 Apr; 43(4):306. PubMed ID: 8713286
    [No Abstract]   [Full Text] [Related]  

  • 39. Visceral leishmaniasis in India.
    Bryceson A
    Lancet; 2000 Dec; 356(9245):1933. PubMed ID: 11130411
    [No Abstract]   [Full Text] [Related]  

  • 40. Leishmania in HLH: a rare finding with significant treatment implications.
    Singh G; Shabani-Rad MT; Vanderkooi OG; Vayalumkal JV; Kuhn SM; Guilcher GM; Steele M
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):e127-9. PubMed ID: 23511497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.